METTL3 depends on YTHDF2 to promote the m6A modification of NUCB1, thereby regulating ATF6, blocking gemcitabine (GEM)-induced autophagy and enhancing the anti-tumor effect of GEM [31]. The gene discussed is METTL3; the disease is neoplasm.